PAR
Click for more information
1.69% 29.0¢ paradigm biopharmaceuticals limited..

Ann: Successful Completion of Entitlement Offer, page-107

  1. Beaza79
    5,051 Posts.
    lightbulb Created with Sketch. 658
    clock Created with Sketch.
    20/09/22
    16:04
    Post #: 63796384
    He isn’t dropping $300k on it to keep us happy irrespective what he earns if he isn’t confident in 1 thing or another imo
    PAR Price at posting: $1.13 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢ 		Change
-0.005(1.69%) 		Mkt cap ! $101.4M
Open High Low Value Volume
29.5¢ 30.0¢ 29.0¢ $19.86K 67.24K

Buyers (Bids)

No. Vol. Price($)
5 38326 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 49869 8
View Market Depth
Last trade - 13.22pm 23/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.